Rosas, I., Bräu, N., Waters, M., Go, R., Malhotra, A., Hunter, B., Bhagani, S., Skiest, D., Savic, S., Douglas, I., Garcia-Diaz, J., Aziz, M., Cooper, N., Youngstein, T., Sorbo, L., Zerda, D., Ustianowski, A., Gracian, A., Blyth, K., Carratalà, J., François, B., Benfield, T., Haslem, D., Bonfanti, P., van der Leest, C., Rohatgi, N., Wiese, L., Luyt, C., Bauer, R., Cai, F., Lee, I., Matharu, B., Metcalf, L., Wildum, S., Graham, E., Tsai, L. & Bao, M. 2022, 'Tocilizumab in patients hospitalised with COVID-19 pneumonia: efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA)', EClinicalMedicine, 47, article no: 101409. http://dx.doi.org/10.1016/j.eclinm.2022.101409